Emcure Pharma IPO: Allotment to Finalize on Monday, 8th July 2024

Upcoming Listing on BSE and NSE

Emcure Pharma's initial public offering (IPO) is poised to finalize its allotment process on Monday, July 8, 2024. The company's shares are set to list on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), with a tentative listing date in the near future.

Early Investment Opportunity

The Emcure Pharmaceuticals Limited IPO presents an exclusive chance for early investment in the reputed pharmaceutical company. The issue encompasses an offer of 19,483,388 equity shares, with 6,743,160 shares allocated for retail investors and 3,853,234 shares reserved for specified entities.

Grey Market Premium and Subscription Details

Based on data from the IPO information platform Chittorgarh IPO, the Emcure Pharma IPO currently enjoys a grey market premium (GMP) of Rs 299. The subscription period has commenced, with the company already securing Rs 582 crore from anchor investors. The price range has been established between Rs 960 and Rs 1008 per share.